Rubicon Research — Quarterly Results & Earnings

₹640.20

+0.00%

Profit Growth YoY56.18%Latest quarter

Sales Growth YoY39.19%Latest quarter

Sales CAGR 5Y37.32%5 year compound

Profit CAGR 5Y22.95%5 year compound

📋

Quarterly Performance

YoY Profit Growth+56.18%

🔥 Exceptional growth

YoY Sales Growth+39.19%

🔥 Exceptional growth

OPM 5Y Average

Operating profit margin

15.50%

EPS Growth 5Y

-37.89%

Interest Coverage

Higher = safer debt servicing

6.29

ROE

29.02%

ROCE

26.16%

💡

Growth Analysis

Rubicon Research reported YoY profit growth of 56.18% and revenue growth of 39.19% in the latest quarter. Double-digit profit growth above 20% is exceptional — indicates strong business momentum. Over 5 years, sales compounded at 37.32% and profits at 22.95% annually. This is above-average growth for Indian listed companies. Consistent growth over 4-8 quarters is more meaningful than any single quarter. Educational data only.

More on Rubicon Research

Overview Financials PE History Shareholding Quarterly Balance Sheet P&L Cash Flow Pharmaceuticals Stocks Screener

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.